* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Supplementary Information (doc 43K)
Survey
Document related concepts
Site-specific recombinase technology wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Epigenetics in learning and memory wikipedia , lookup
Designer baby wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Transcript
Tomasini et al. SUPPORTING INFORMATION Supporting Materials and Methods Real-time PCR primers. Primers for real-time PCR reactions were as follows. Cxcl11-forward: GGCTTCCTTATGTTCAAACAGGG, GCCGTTACTCGGGTAAATTACA; GCAGGATTTCCACCTGGCTA; GGCAGTGTAACTCTTCTGCAT; Id3-forward: IFN-forward: reverse: GTCACAGCACATGACGGAGG, GCCGTTCAAGTGCTTCACTC, TAp73-forward: GCACTGCTGAGCAAATTGAAC; Np73-reverse: CGACCGAGGAGCCTCTTAG, CAGCTCCAAGAAAGGACGAAC, Cald1-forward: TGTCAATCTTGGAGACTACTGCT; Cxcl-11-reverse: Id3-reverse IFN-reverse: Cald1-reverse: GCACCTACTTTGACCTCCCC, Np73-forward: TAp73- CCCACCACTTCGAGGTCAC, GGCATGTCTTAGCAATCTGACAG; p53-forward: p53-reverse: TCTTCCAGATGCTCGGGATAC. Apoptosis. Plated cells were stimulated for 24 or 48hrs with TGF (20ng/ml, Peprotech), Staurosporine (200nM, Sigma-Aldrich), Etoposide (50µM, SigmaAldrich), LPS (100ng/ml, Sigma-Aldrich), IFN (5ng/ml, eBiosciences) or LPS/IFN (100ng/ml, 5ng/ml). Apoptosis was evaluated by flow cytometry or caspase-3 cleavage. For the former, stimulated cells were incubated with 500µg/ml propidium iodide (PI, Fluo Probes, Interchim) and stained with AnnexinV-APC (BD Biosciences) following the manufacturer’s protocol. Stained cells were analyzed using a FACSCalibur (Becton Dickinson Biosciences) and data were analyzed with CellQuestTM Pro (BD Biosciences) and FlowJo 7.2.2 Data Analysis Software. For measurements of the activities of caspases 3 and 7, the Caspase-Glo®3/7 Assay (Promega, Mannheim, Germany) was carried out according to the manufacturer’s instructions. This kit is based on the cleavage of the DEVD sequence of a luminogenic substrate by the caspases 3 and 7 resulting in a luminescent signal. 1 Tomasini et al. Cytokines. IL-6 and TNFα levels data from Figure 1D and E were determined in triplicate using commercial ELISA kits according to the manufacturer’s (BD Biosciences) protocol. IL-12p70, MIP2, TNFα, IL-6 and IFNγ levels in culture supernatants or serum samples were determined in triplicate using Searchlight® Protein Array Analysis Services from Pierce Biotechnology. cDNA microarray analysis of gene expression. Elicited peritoneal macrophages were treated in vitro (or not; control) with 10 µg/ml LPS. After 0, 4 or 12 hrs, total RNA was extracted using Trizol Reagent (Invitrogen) according to the manufacturer’s protocol. RNA hybridization to a mouse gene expression array (MOE 430 2.1) was performed by the Microarray Platform at the CHUL Research Center of the Quebec Genomics Center (http://genome.ulaval.ca/chip). Tissue damage scoring Pancreas and Liver tissues were examined histopathologically for tissue damage scoring. The pathologist blinded as to which group an animal belonged. Tissue edema formation, infiltration of the inflammatory cells and necrosis area were scored between 0 and 3. According to this scoring system: 0) Normal tissue; 1) small perivascular edema formation/few neutrophil leukocyte infiltration/small necrosis area; 2) milder perivascular edema formation/moderate neutrophil leukocyte infiltration/milder necrosis area; 3) Important perivascular edema/dens neutrophil leukocyte infiltration/important necrosis area; Immunoprecipitation 2 Tomasini et al. Elicited peritoneal macrophages from TAp73+/+ mice were treated for increasing period of time from 10 to 120 minutes with LPS (10µg/ml). Then cells were lysed in ice-cold 1% Triton X-100 buffer (pH 7.5) containing protease inhibitors. The lysates were cleared by centrifugation at 13 000 r.p.m for 15min at 4°C. Immunoprecipitations using the cleared cell lysates were performed at 4°C for 2 h with TAp73 antibody (H79, Santa Cruz Biotechnology, Inc). Immune-complexes were precipitated with protein A (Zymed Laboratories,San Francisco, CA, USA) for an additional 1 h and washed three times with lysis buffer. They were then resuspended in Laemmli sample buffer and boiled for 5min. The proteins were then resolved on sodium dodecyl sulfate–polyacrylamidegel electrophoresis and transferred to nirocellulose filters. Classical procedure was then used for western blot process using either TAp73 antibodies (H79) or mouse phospho-tyrosine (Cell Signaling Technology, 9411) as primary antibodies. Development was done using ECL kit from Amersham Biosciences (Saclay, France). The bands obtained from three independent experiments were quantified using ImageJ software and normalized with respect to the control bands. Chromatin Immunoprecipitation The chromatin immunprecipitation assays were done following a protocol provided by Millipore Inc. using the premade assay kit “EZ-ChIPTM” (Millipore Inc, 17-371). This protocol was used on WT EPMs after 12 hrs of LPS treatment (10µg/ml). TAp73 antibody (H79, Santa Cruz Biotechnology, Inc) was used for the immunoprecipitation step and incubated with protein G agarose beads included in the assay kit. DNAs were purified using a PCR purification kit (Promega) and then analyzed by regular PCR 3 Tomasini et al. using the mouse Mgat5, Frp1, Fosl2, p57/Kip2, G-CSF (CSF3) and IL4i1 promoterspecific primers. 4 Tomasini et al. Supporting Figure Legends Fig. S1. Accelerated tissue damage in LPS-treated TAp73-deficient mice. WT and TAp73-/- mice were i.p. injected with a lethal dose of LPS (25mg/kg). At 6 hrs postLPS, inflammation in the pancreas and liver were histopathologically scored as described in Supplemental Methods. Ed, Edema; Infil, Immune cell infiltration; Nec, Necrosis area. Data are the mean ± SD of data pooled from two experiments involving 3 mice/group/experiments. *, P<0.05 (Student t-test). Fig. S2. Loss of Np73 isoforms does not confer hypersensitivity to LPS-induced septic shock. A lethal dose of LPS (25mg/kg body weight; Sigma) was i.p. injected into WT and Np73-deficient male mice (10-14 weeks old). Survival was monitored for 100 hrs. P=0.592 (log-rank test). Fig. S3. Induction of TAp73 after LPS treatment. (A) WT or TAp73-/- EPMs were treated for increasing period of time from 1 to 9 hrs with LPS (10 μg/ml) and levels of TAp73, Np73 and p53 mRNAs were determined by Real-time PCR. Data shown are the mean fold change ± SD in mRNA expression after LPS treatment. Results are one trial representative of 3 independent experiments. ND means not determined. (B) WT EPMs were treated for increasing period of time from 10 to 120 min with LPS (10 μg/ml) and cell lysates were prepared for immunoprecipitation using TAp73 antibody then western blot with phospho-tyrosine antibody. Results are one trial representative of 3 independent experiments. Data shown in the diagram are the mean fold change ± SD in tyrosine phosphorylated TAp73 after LPS treatment. *, P<0.05; **, P<0.01 (Student t-test). 5 Tomasini et al. Fig. S4. F4/80+ macrophages content in total cells from peritoneal washes. (A) Representative flow cytometric histogram. Ctr, control (F4/80 negative staining). (B to D) Percentage of total cells expressing, or not, F4/80 (macrophages) are shown regarding Figure 2B (for B), Figures 2C (for C) and 2D ( forD), respectively. Figure S5. Expression of key genes involved in apoptosis/survival regulation. Data generated from cDNA microarray analysis. Fold change represents the ratio of the hybridization intensity of a given gene in TAp73-/- EPMs compared to WT EPMs. Data are shown for the “no treatment” condition (0), and for LPS treatment for 4 hrs (4h-LPS) or 12 hrs (12h-LPS). Column 5 to 7 are showing raw value data from microarray analysis. Only genes for which a statistical difference of P<0.01 was obtained are shown. A fold change filter of 1.5 (or -1.5) was used. The p53RE column contains results obtained from the p53 Family Target Genes Database, where the presence of a p53-responsive element was observed in an intron (I), the promoter region (P), or in the 3’UTR (U). Figure S6. Expression of key genes involved in macrophage metabolism and immune response. Data generated from cDNA microarray analysis. Fold-change represents the ratio of the hybridization intensity of a given gene in TAp73-/- EPMs compared to WT EPMs. Data are shown for the “no treatment” condition (0), and for LPS treatment for 4 hrs (4h-LPS) or 12 hrs (12h-LPS). Column 5 to 7 are showing raw value data from microarray analysis. Only genes for which a statistical difference of P<0.01 was obtained are shown. A fold-change filter of 1.5 (or -1.5) was used. The p53RE column contains results obtained from the p53 Family Target Genes Database, 6 Tomasini et al. where the presence of a p53-responsive element was observed in an intron (I), the promoter region (P), or in the 3’UTR (U). Fig. S7. Modulation of other gene expression profiles as determined by cDNA microarray analysis. (A) WT or TAp73-/- EPMs were treated for increasing period of time from 1 to 9 hrs with LPS (10 μg/ml) and levels of 1) Id3 mRNA was determined by Real-time PCR. Data shown are the mean fold change ± SD in mRNA expression after LPS treatment. Results are one trial representative of 3 independent experiments. (B) Liver tissue. WT and TAp73-/- mice were treated with LPS (25mg/kg) for 1.5 or 6 hrs. Liver tissues were recovered and levels of 1) Cald1 and 2) Id3 mRNAs were determined as in (A). Data are the mean fold change ± SD in mRNA level (n=3 mice/group). Results are representative of 2 independent experiments. For A and B, *, P<0.05; **, P<0.01 (Student t-test). Fig. S8. Loss of TAp73 protects EPMs from some apoptotic stimuli. (A) LPSinduced apoptosis. WT and TAp73-/- EPMs were treated in vitro for 12 hrs with the indicated doses of LPS. PI/AnnexinV positivity was determined as described in Methods. (B) Other apoptotic stimuli. WT and TAp73-/- EPMs were treated with the indicated apoptotic stimuli (see Methods) for 24 hrs, and caspase-3 activity was determined as for Figure 4A. Stauro, staurosporine; Etop, etoposide. For A and B, data are the mean ± SD of pooled results from 2 experiments, each involving EPMs from 2 mice/genotype. *P<0.05, **P<0.01 (Student t-test). 7